Demyelination followed by axonal damage is a common and integral component of demyelinating diseases, and our work identifying cyclo-dPAKKR exerts p75NTR-dependent neuroprotective effects on EAN provides new insight into the future development of neuroprotective therapeutics for peripheral demyelinating diseases. The gene discussed is NGFR; the disease is demyelinating disease.